Skip to contentG
Gossamer Bio, Inc.
G
GOSSGossamer Bio, Inc. Q1 2024 · 10-Q
Revenue$0.00$0.00no prior Q1 2023 on file Net Income-$41.93M-$41.93MN/M vs Q1 2023 EPS Diluted-$0.19-$0.19N/M vs Q1 2023 Operating Income-$41,959,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
Free Cash Flowderived-$52,302,000N/M ended Mar 31, 2024 · filed May 7, 2024 · 37 d after period end